• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov18
Lake Street analyst maintains a Buy rating on Immunome with a price target of $22
14:02
Nov7
Immunome released FY2025 9 Months Earnings on November 6 (EST), actual revenue USD 6.941 M, actual EPS USD -1.6763
04:00
Immunome released FY2025 Q3 earnings on November 6, 2025 (EST), actual revenue USD 0 (forecast USD 611.11K), actual EPS USD -0.6532 (forecast USD -0.5759)
04:00
Nov3
Amin Focuses on Healthcare Sector Stocks
19:02
Oct23
Immunome Inc. Unveils Preclinical Data of ADC Payload HC74 at Conference
16:00
Oct7
Charles Zhu Reiterates Buy Rating on Immunome
10:47

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -57.46 M, EPS -0.6532

Aug6
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.015 M, Net Income -43.4 M, EPS -0.4987

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 2.926 M, Net Income -41.64 M, EPS -0.5243

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
BBGI
16.690
+312.10%
+12.640
SRV.RT
0.0900
+111.76%
+0.048
BEAT
1.550
+92.43%
+0.745
ENVB
10.330
+74.49%
+4.410
BDRX
6.720
+65.11%
+2.650
ASPC
16.810
+60.40%
+6.330
IRBT
5.240
+48.44%
+1.710
CGTL
0.9727
+47.40%
+0.313
MIGI
6.700
+45.65%
+2.100
PLAB
37.350
+45.39%
+11.660
View More